Validation of the Modified Microlife Blood Pressure Monitor in PAF
Research type
Research Study
Full title
Validation of the Modified Microlife Blood Pressure Monitor in Patients with Paroxysmal Atrial Fibrilation
IRAS ID
114264
Contact name
Gregory YH Lip
Contact email
Research summary
120 patients with an implanted pacemaker who have previously documented fast atrial fibrillation (irregular heart beat) with episodes of a very fast heart rate (high-rate atrial episodes), will be randomly selected from the pacemaker register at City Hospital, Birmingham UK and invited to participate, to enable at least 80 patients to be recruited. Following written informed consent, patients will be fitted the automated blood pressure monitor (Microlife WatchBP03) by a researcher. Blood pressure will be monitored during a 24-hour period using the ambulatory function on the device. Atrial fibrillation will also be detected throughout this 24-hour period by the device using an inbuilt algorithm. Following removal of the device, the previous 24-hour period’s data will be downloaded from the pacemaker by the cardiac technician and interpreted by both the technician and a cardiologist independently. The data from the Microlife WatchBP03 device will be downloaded by the researcher. The level of agreement between the pacemaker and the Microlife WatchBP03 device recordings will be assessed statistically. Sensitivity and specificity of the Microlife WatchBP03 device will be calculated.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
13/WM/0382
Date of REC Opinion
14 Oct 2013
REC opinion
Favourable Opinion